John F. Chin
Director/Board Member at ANTENGENE CORPORATION LIMITED
Net worth: 233 244 $ as of 2024-03-30
Profile
John F.
Chin is currently the Executive Director & Chief Business Officer at Antengene Corporation Co., Ltd.
and Antengene Corp.
Ltd.
He previously worked as the Senior Director-Corporate Accounting Management at Celgene Corp.
from 2005 to 2020.
Prior to that, he was an Associate Product Manager at Aventis Pharmaceuticals, Inc. starting in 1998.
Mr. Chin holds an MBA from Pepperdine University, which he received in 1998, and an undergraduate degree from the University of Arizona, which he received in 1989.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-11-10 | 1,825,496 ( 0.27% ) | 233 244 $ | 2024-03-30 |
John F. Chin active positions
Companies | Position | Start |
---|---|---|
ANTENGENE CORPORATION LIMITED | Director/Board Member | 2020-08-17 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 1998-09-30 |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - |
Former positions of John F. Chin
Companies | Position | End |
---|---|---|
CELGENE | Corporate Officer/Principal | 2019-12-31 |
Training of John F. Chin
Pepperdine University | Masters Business Admin |
University of Arizona | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ANTENGENE CORPORATION LIMITED | Health Technology |
Private companies | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- John F. Chin